Renin-angiotensin-aldosterone system (RAAS) blockers, such as ACE inhibitors and/or ARBs, have been proven beneficial for proteinuric CKD patients and are widely prescribed by physicians [18]. This evidence concerns the gene REN and chronic kidney disease.